A study suggests that the availability of orphan drugs varies significantly between different countries in Europe.
25 April 2018
23 April 2018
A report by Pharmaceutical Research and Manufacturers of America (PhRMA) has found that over 500 medicines for neurological disorders are currently in development.
6 April 2018
The market for age-related macular degeneration (AMD) drugs could grow at a compound annual growth rate of 8.9% and reach $11.5bn by 2026, according to a report.
2 March 2018
Late-stage chronic kidney disease (CKD) induced hyperparathyroidism (HPT), hyperphosphatemia (HP), and hyperkalemia (HK) therapeutics market is set to grow from $4.2bn in 2016 to $10.5bn in 2026 at a compound...
27 February 2018
Pfizer could owe NHS England over £5 million in prescribing costs if it loses a patent appeal for painkiller and epilepsy drug pregabalin , branded Lyrica, according to a study.
23 February 2018
The requirement for effective supportive care of cancer patients is expected to grow over the coming decade as survival rate increases and disease progression results in a chronic condition, according...
16 February 2018
Sales of melanoma-treating drugs will grow from an estimated $3.3bn during 2016 to $5.5bn in 2026, according to a report by GlobalData.
9 February 2018
The global glaucoma market is expected to witness a compound annual growth rate (CAGR) of 4.1%, rising from $2.6bn in 2016 to $3.8bn in 2026, according to a report by...
26 January 2018
Pharmaceutical Research and Manufacturers of America (PhRMA) spent $25.4 million lobbying the US Congress during 2017.
15 December 2017
Sales of multiple sclerosis (MS) disease-modifying therapies (DMTs) are projected to grow from $19.1bn in 2016 to $25.3bn in 2026, according to a report by GlobalData.